APGE
Apogee Therapeutics, Inc.
NASDAQ · USHealthcareBiotechnology
$134.07+0.06%
Price as of Jul 20, 2026
APGE ownership
Apogee Therapeutics, Inc. ownership & insider activity
Latest available institutional positioning and SEC Form 4 insider transactions, coalesced at the company entity level when listings share coverage.
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
18
Net (3m)
-$21.9M
Insider trades by month Buys Sells
Feb
Mar
Apr
May
Jun
Jul
Context3-month price +47.7%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 10, 2026 | HENDERSON MICHAEL THOMASdirector, officer: Chief Executive Officer | Sell | 20,000 | $133.63 |
| Jul 2, 2026 | Dambkowski Carlofficer: Chief Medical Officer | Option | 4,125 | $22.86 |
| Jul 2, 2026 | Dambkowski Carlofficer: Chief Medical Officer | Sell | 5,500 | $132.74 |
| Jun 24, 2026 | Dambkowski Carlofficer: Chief Medical Officer | Sell | 26,400 | $132.60 |
| Jun 24, 2026 | HENDERSON MICHAEL THOMASdirector, officer: Chief Executive Officer | Sell | 80,000 | $132.54 |
| Jun 12, 2026 | HENDERSON MICHAEL THOMASdirector, officer: Chief Executive Officer | Sell | 1,080 | $84.18 |
| Jun 12, 2026 | HENDERSON MICHAEL THOMASdirector, officer: Chief Executive Officer | Sell | 6,770 | $82.21 |
| Jun 12, 2026 | HENDERSON MICHAEL THOMASdirector, officer: Chief Executive Officer | Sell | 7,654 | $82.78 |
| Jun 12, 2026 | HENDERSON MICHAEL THOMASdirector, officer: Chief Executive Officer | Sell | 614 | $86.89 |
| Jun 12, 2026 | HENDERSON MICHAEL THOMASdirector, officer: Chief Executive Officer | Sell | 2,305 | $86.27 |
| Jun 12, 2026 | HENDERSON MICHAEL THOMASdirector, officer: Chief Executive Officer | Sell | 1,577 | $85.19 |
| Jun 11, 2026 | Fox Jennifer A.director | Grant | 7,657 | $85.00 |
| Jun 11, 2026 | Shah Nimish Pdirector | Grant | 7,657 | $85.00 |
| Jun 11, 2026 | McKenna Mark C.director | Grant | 7,657 | $85.00 |
| Jun 11, 2026 | JONES WILLIAM A JRdirector | Grant | 7,657 | $85.00 |
| Jun 11, 2026 | Bollinger Lisadirector | Grant | 7,657 | $85.00 |
| Jun 11, 2026 | Fairmount Funds Management LLCdirector | Grant | 7,657 | $85.00 |
| Jun 5, 2026 | Dambkowski Carlofficer: Chief Medical Officer | Option | 4,125 | $22.86 |
| Jun 5, 2026 | Dambkowski Carlofficer: Chief Medical Officer | Sell | 5,500 | $78.71 |
| May 15, 2026 | HENDERSON MICHAEL THOMASdirector, officer: Chief Executive Officer | Sell | 18,659 | $82.05 |
| May 15, 2026 | HENDERSON MICHAEL THOMASdirector, officer: Chief Executive Officer | Sell | 1,341 | $82.58 |
| May 8, 2026 | Dambkowski Carlofficer: Chief Medical Officer | Sell | 3,700 | $83.92 |
| May 8, 2026 | Dambkowski Carlofficer: Chief Medical Officer | Option | 4,125 | $22.86 |
| May 8, 2026 | Dambkowski Carlofficer: Chief Medical Officer | Sell | 1,800 | $84.60 |
| May 4, 2026 | Henderson Janeofficer: Chief Financial Officer | Sell | 811 | $81.02 |
| May 4, 2026 | Henderson Janeofficer: Chief Financial Officer | Sell | 289 | $83.16 |
| May 4, 2026 | Henderson Janeofficer: Chief Financial Officer | Sell | 900 | $82.60 |
| Apr 20, 2026 | HENDERSON MICHAEL THOMASdirector, officer: Chief Executive Officer | Option | 3,000 | $22.86 |
| Apr 17, 2026 | Henderson Janeofficer: Chief Financial Officer | Sell | 2,000 | $90.00 |
| Apr 10, 2026 | HENDERSON MICHAEL THOMASdirector, officer: Chief Executive Officer | Sell | 200 | $85.00 |
Source: APGE SEC Form 4 filings, latest Jul 10, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their APGE positions over the last 6 months (SEC Form 13F).
Increased
203
New positions
101
Reduced
98
Sold out
52
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | Increased | 10.3M | May 15, 2026 |
| FMR LLC | Increased | 9.3M | May 15, 2026 |
| VR ADVISER, LLC | Unchanged | 8.5M | May 15, 2026 |
| VR ADVISER, LLC | Unchanged | 8.5M | Feb 17, 2026 |
| FMR LLC | Increased | 8.2M | Feb 17, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Increased | 4.7M | Feb 17, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Reduced | 4.4M | May 15, 2026 |
| BLACKROCK, INC. | Increased | 4.1M | May 13, 2026 |
| BLACKROCK, INC. | Increased | 3.8M | Feb 12, 2026 |
| VANGUARD GROUP INC | Increased | 2.9M | Jan 29, 2026 |
| RTW INVESTMENTS, LP | Increased | 2.8M | May 15, 2026 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | Increased | 2.7M | Feb 19, 2026 |
| RTW INVESTMENTS, LP | Unchanged | 2.7M | Feb 17, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 2.5M | May 15, 2026 |
| JANUS HENDERSON GROUP PLC | Increased | 2.4M | May 18, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.